Navigation Links
ProCure Signs Agreement with .decimal, Inc. to Purchase Patient-Specific Devices for Its Proton Therapy Center in Oklahoma City

SANFORD, Fla., Feb. 3 /PRNewswire/ -- .decimal, Inc. announced today that it has signed an agreement with ProCure Treatment Centers, Inc. to supply patient-specific devices for its proton therapy facility in Oklahoma City, Oklahoma.

(Logo: )

".decimal is excited to have a formal agreement signed with ProCure to be their preferred outsource provider of custom, patient-specific devices utilizing our patented, internet-based manufacturing solution," says Richard Sweat, CEO and President of .decimal.

This agreement calls for proton range compensators and apertures to be manufactured in Sanford, Florida and shipped to the facility in Oklahoma within 24-72 hours. Mark Mills, Senior Vice President of Sales and Marketing for .decimal says, "Signing with ProCure just further strengthens the commitment we have made to the proton therapy industry and specifically to their state-of-the-art facility in Oklahoma City."

.decimal, Inc. has been supplying patient-specific medical devices, as well as other custom machining projects for the University of Florida Proton Therapy Institute since June of 2007. This partnership continues to demonstrate why .decimal, Inc. is the industry leader in partnering with proton therapy facilities worldwide.

"We are proud to partner with ProCure as they roll out proton therapy around the world," says Sweat.

As well as working with proton facilities, .decimal, Inc. supplies close to 200 radiation oncology facilities nationwide with patient-specific devices used in Compensator-Based Intensity Modulated Radiation Therapy (IMRT), including 21st Century Oncology sites and H. Lee Moffitt Cancer and Research Center.

With the addition of the facility in Oklahoma, .decimal will continue to develop new and innovative technologies which will increase patient throughput while providing high quality devices to the patients in Oklahoma City.

.decimal is a medical device manufacturer of patient-specific devices, including missing tissue compensators, modulators for advanced Compensator-Based IMRT delivery, as well as apertures and range compensators used in proton therapy. The company has been providing radiation therapy products for over twenty years. For more information concerning .decimal, please see its Web site at

SOURCE .decimal, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. PharmAthene Response to DHHS Request for Proposals for Recombinant Protective Antigen Anthrax Vaccine Deemed Technically Acceptable and Within Competitive Range for Procurement Consideration
2. SciQuest Announces Newest Life Sciences Customer; BioMarin Pharmaceutical Drives Spending Effectiveness with Automated, Intuitive Procurement
3. Array BioPharma Selects SciQuest to Automate Procurement and Enable Agile Drug Development
4. ProCure Selects IMPAC as Provider of Oncology Information Systems
5. SciQuest Continues to Surpass Milestones for Customer Wins, Growth and Market Share; Remains Clear Eprocurement Leader for Academic and Research-Centric Organizations
6. AmSurg Selects SciQuest Eprocurement Solution to Automate Purchasing of Medical Goods and Services
7. Signalife Continues to Procure Purchase Orders, Revenues
8. University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement
9. Traditional Risk Factors Often Miss Heart Disease Warning Signs
10. Sigma-Aldrich Signs Agreement With CPC Scientific for the Distribution of PEPscreen(R) Custom Peptide Libraries
11. Encorium Group Signs $3.1 Million of New Business Contracts Including an Extension of a Current U.S. Oncology Clinical Trial with a Major Pharmaceutical Company
Post Your Comments:
(Date:6/24/2016)... NC (PRWEB) , ... June 24, 2016 , ... Researchers ... the most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are ... to read it now. , Diagnostic biomarkers are signposts in the blood, lung ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... 23, 2016 , ... STACS DNA Inc., the sample tracking software company, today ... Laboratory, has joined STACS DNA as a Field Application Specialist. , “I am ... and COO of STACS DNA. “In further expanding our capacity as a scientific integrator, ...
Breaking Biology Technology:
(Date:6/22/2016)... 22, 2016 On Monday, the Department of ... to share solutions for the Biometric Exit Program. The ... Border Protection (CBP), explains that CBP intends to add ... the United States , in order to ... imposters. Logo - ...
(Date:6/9/2016)... attendance control systems is proud to announce the introduction of fingerprint attendance control software, ... employees are actually signing in, and to even control the opening of doors. ... ... ... Photo - ...
(Date:6/2/2016)... --  The Weather Company , an IBM Business (NYSE: ... in which consumers will be able to interact with IBM ... voice or text and receive relevant information about the product ... have long sought an advertising solution that can create a ... and valuable; and can scale across millions of interactions and ...
Breaking Biology News(10 mins):